Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany.
Jena University Hospital, Friedrich Schiller University, Institute of Human Genetics, Jena, Germany.
Life Sci. 2021 Feb 15;267:118922. doi: 10.1016/j.lfs.2020.118922. Epub 2020 Dec 21.
We systematically characterized metastatic murine B16-F10 melanoma, a sub-line derived from murine melanoma B16-F1 cells.
RNA-sequencing and network analyses (Ingenuity Pathway Analysis) were performed to identify novel potential metastasis mechanisms. Chromosomal aberrations were identified by multicolor fluorescence in situ hybridization (mFISH) using all 21 murine whole chromosome painting probes.
Numerous genes were overexpressed in B16-F10 cells, some of which have been already described as being metastasis-linked. Nr5a1/sf1, a known prognostic marker for adrenal tumors, was 177-fold upregulated in B16-F10 cells compared to B16-F1 cells. Hoxb8 was 75-fold upregulated, which was previously associated with gastric cancer progression and metastasis. Ptk7, which is linked with tumorigenesis and metastasis of esophageal squamous carcinoma, was 67-fold upregulated. B16-F10 cells acquired additional chromosomal aberrations compared to B16-F1 cells, including dic(4)(pter->qter:qter->pter), +dic(6;15), +der(10)t(10;?1;16).
In addition to well-known metastatic genes, numerous novel genes and genomic aberrations were identified, which may serve as targets for treatment in the future. Transcriptomic and genetic analyses in B16-F10 cells unraveled a range of novel metastasis mechanisms, which may also have important implications for future treatment strategies.
我们系统地研究了转移性鼠 B16-F10 黑色素瘤,这是源自鼠黑色素瘤 B16-F1 细胞的一个亚系。
采用 RNA 测序和网络分析(Ingenuity Pathway Analysis)来鉴定新的潜在转移机制。通过使用 21 个全鼠染色体涂染探针的多色荧光原位杂交(mFISH)来鉴定染色体畸变。
B16-F10 细胞中大量基因过表达,其中一些基因已被描述为与转移相关。Nr5a1/sf1 是肾上腺肿瘤的已知预后标志物,在 B16-F10 细胞中的表达水平比 B16-F1 细胞高 177 倍。Hoxb8 的表达水平上调了 75 倍,先前与胃癌的进展和转移有关。Ptk7 与食管鳞状细胞癌的发生和转移有关,在 B16-F10 细胞中的表达水平上调了 67 倍。与 B16-F1 细胞相比,B16-F10 细胞获得了额外的染色体畸变,包括 dic(4)(pter->qter:qter->pter)、+dic(6;15)、+der(10)t(10;?1;16)。
除了众所周知的转移基因外,还鉴定了许多新的基因和基因组畸变,它们可能成为未来治疗的靶点。B16-F10 细胞的转录组和遗传分析揭示了一系列新的转移机制,这对未来的治疗策略也可能具有重要意义。